Literature DB >> 21839614

GRADE guidelines 6. Rating the quality of evidence--imprecision.

Gordon H Guyatt1, Andrew D Oxman, Regina Kunz, Jan Brozek, Pablo Alonso-Coello, David Rind, P J Devereaux, Victor M Montori, Bo Freyschuss, Gunn Vist, Roman Jaeschke, John W Williams, Mohammad Hassan Murad, David Sinclair, Yngve Falck-Ytter, Joerg Meerpohl, Craig Whittington, Kristian Thorlund, Jeff Andrews, Holger J Schünemann.   

Abstract

GRADE suggests that examination of 95% confidence intervals (CIs) provides the optimal primary approach to decisions regarding imprecision. For practice guidelines, rating down the quality of evidence (i.e., confidence in estimates of effect) is required if clinical action would differ if the upper versus the lower boundary of the CI represented the truth. An exception to this rule occurs when an effect is large, and consideration of CIs alone suggests a robust effect, but the total sample size is not large and the number of events is small. Under these circumstances, one should consider rating down for imprecision. To inform this decision, one can calculate the number of patients required for an adequately powered individual trial (termed the "optimal information size" [OIS]). For continuous variables, we suggest a similar process, initially considering the upper and lower limits of the CI, and subsequently calculating an OIS. Systematic reviews require a somewhat different approach. If the 95% CI excludes a relative risk (RR) of 1.0, and the total number of events or patients exceeds the OIS criterion, precision is adequate. If the 95% CI includes appreciable benefit or harm (we suggest an RR of under 0.75 or over 1.25 as a rough guide) rating down for imprecision may be appropriate even if OIS criteria are met.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21839614     DOI: 10.1016/j.jclinepi.2011.01.012

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  638 in total

1.  The Practice Guidelines for Primary Care of Acute Abdomen 2015.

Authors:  Toshihiko Mayumi; Masahiro Yoshida; Susumu Tazuma; Akira Furukawa; Osamu Nishii; Kunihiro Shigematsu; Takeo Azuhata; Atsuo Itakura; Seiji Kamei; Hiroshi Kondo; Shigenobu Maeda; Hiroshi Mihara; Masafumi Mizooka; Toshihiko Nishidate; Hideaki Obara; Norio Sato; Yuichi Takayama; Tomoyuki Tsujikawa; Tomoyuki Fujii; Tetsuro Miyata; Izumi Maruyama; Hiroshi Honda; Koichi Hirata
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Changing Clinical and Therapeutic Trends in Tentorial Dural Arteriovenous Fistulas: A Systematic Review.

Authors:  D Cannizzaro; W Brinjikji; S Rammos; M H Murad; G Lanzino
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-27       Impact factor: 3.825

Review 3.  Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis.

Authors:  Giovanni Barosi
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

Review 4.  Dressings and topical agents for treating pressure ulcers.

Authors:  Maggie J Westby; Jo C Dumville; Marta O Soares; Nikki Stubbs; Gill Norman
Journal:  Cochrane Database Syst Rev       Date:  2017-06-22

Review 5.  Patient-controlled analgesia with remifentanil versus alternative parenteral methods for pain management in labour.

Authors:  Stephanie Weibel; Yvonne Jelting; Arash Afshari; Nathan Leon Pace; Leopold Hj Eberhart; Johanna Jokinen; Thorsten Artmann; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2017-04-13

Review 6.  Oxygen saturation target range for extremely preterm infants: a systematic review and meta-analysis.

Authors:  Veena Manja; Satyan Lakshminrusimha; Deborah J Cook
Journal:  JAMA Pediatr       Date:  2015-04       Impact factor: 16.193

Review 7.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

Review 8.  Endovascular Treatment of Ruptured Blister-Like Aneurysms: A Systematic Review and Meta-Analysis with Focus on Deconstructive versus Reconstructive and Flow-Diverter Treatments.

Authors:  A Rouchaud; W Brinjikji; H J Cloft; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2015-09-17       Impact factor: 3.825

9.  Thrombolytics for venous thromboembolic events: a systematic review with meta-analysis.

Authors:  Ariel Izcovich; Juan M Criniti; Federico Popoff; Liming Lu; Jiaming Wu; Walter Ageno; Daniel M Witt; Michael R Jaff; Sam Schulman; Veena Manja; Peter Verhamme; Gabriel Rada; Yuqing Zhang; Robby Nieuwlaat; Wojtek Wiercioch; Holger J Schünemann; Ignacio Neumann
Journal:  Blood Adv       Date:  2020-04-14

Review 10.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.